TER was synthesized from dimethyl l-tartrate. All spectra, including 1H and 13C nuclear magnetic resonance (NMR) spectra, infrared (IR) spectra, and specific rotation of the synthetic TER, were similar to those of natural TER and those that were previously described (Mandai et al., 2014). The following were used: human soluble RANKL (Wako, Hiroshima, Japan), human M-CSF (Leucoprol, Kyowa Hakko Kogyo, Japan), zoledronic acid (ZOL: Tokyo Chemical Industry, Japan), rabbit anti-total PKCα, rabbit anti–phospho-PKCα/βII and PKCδ monoclonal antibodies (Cell Signaling Technology Danvers, MA, United States), mouse anti–β-actin monoclonal antibody (Sigma-Aldrich, St. Louis, MO, United States), and the PKC inhibitor GF109203X (Bisindolylmaleimide I, Selleckchem, Japan).

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.